Skip to main content
SpringerLink
Log in

Cytogenetic Findings in Myeloproliferative Disorders

  • Conference paper
Chronic Myelocytic Leukemia and Interferon

Abstract

Our comprehension of the significance of specific and nonrandom chromosome changes in leukemia and other malignant diseases has increased enormously during the last decade. The rise of tumor cytogenetics was caused by the development of refined chromosome banding techniques which allowed the detection of chromosomal rearrangements that had previously been overlooked. With the improvement of these techniques, chromosome anomalies can now be demonstrated in many more patients with malignant tumors and premalignant diseases than had been imagined only a few years ago.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bartram CR, Anger B, Carbonell F, Kleihauer E (1985) Involvement of chromosome 9 in variant Ph1 translocation. Leuk Res 9: 1133–1137

    Article  PubMed  CAS  Google Scholar 

  2. Bartram CR, Kleihauer E, de Klein A, Grosveld G, Teyssier JR, Heisterkamp N, Groffen J (1985) c-abl and bcr are rearranged in a Ph1-negative CML patient. EMBO J 4: 683–686

    PubMed  CAS  Google Scholar 

  3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33: 451–458

    Article  PubMed  CAS  Google Scholar 

  4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199

    PubMed  CAS  Google Scholar 

  5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Criteria for the diagnosis of acute leukaemia of megakaryocytic lineage (M 7). Ann Intern Med 103: 460–462

    PubMed  CAS  Google Scholar 

  6. Bernstein R, Pinto MR, Behr A, Mendelow B (1982) Chromosome 3 abnormalities in acute nonlymphocytic leukemia (ANLL) with abnormal thrombopoiesis: report of three patients with a “new” inversion anomaly and a further case of homologous translocation. Blood 60: 613–617

    PubMed  CAS  Google Scholar 

  7. Bernstein R, Bagg A, Pinto M, Lewis D, Mendelow B (1986) Chromosome 3q21 abnormalities associated with hyperactive thrombopoiesis in acute blastic transformation of chronic myeloid leukemia. Blood 68: 652–657

    PubMed  CAS  Google Scholar 

  8. Caspersson T, Gahrton G, Lindsten J, Zech L (1970) Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis. Exp Cell Res 63: 238–240

    Article  PubMed  CAS  Google Scholar 

  9. De Klein A, Geurts van Kessel A, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300: 765–767

    Article  PubMed  Google Scholar 

  10. Fonatsch C, Stollmann B, Holldack J, Engert A (1987) Translocation (6;9)(p23;q34) in smoldering leukemia and acute nonlymphocytic leukemia. Cancer Genet Cytogenet 26: 363–368

    Article  PubMed  CAS  Google Scholar 

  11. Groffen J, Heisterkamp N, Stephenson JR, Geurts van Kessel A, de Klein A, Grosveld G, Bootsma D (1983) c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. J Exp Med 158: 9–15

    Google Scholar 

  12. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36: 93–99

    CAS  Google Scholar 

  13. Hagemeijer A, Bartram CR, Smit EME, van Agthoven AJ, Bootsma D (1984) Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation? Cancer Genet Cytogenet 13: 1–16

    Article  PubMed  CAS  Google Scholar 

  14. Hayata I, Kakati S, Sandberg AA (1973) A new translocation related to the Philadelphia chromosome. Lancet 2: 1385

    Article  PubMed  CAS  Google Scholar 

  15. Human Gene Mapping 8 (1985) Eighth International Workshop on Human Gene Mapping. Cytogenet Cell Genet vol 40, 1985

    Google Scholar 

  16. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD (1986) Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 67: 1765–1772

    PubMed  CAS  Google Scholar 

  17. Janossy G, Woodruff RK, Pipard MJ, Prentice HG, Hoffbrand AV, Paxton A, Bunch C, Greaves MF (1979) Relation of “lymphoid” phenotype and response to chemotherapy incorporating vincristine-prednisolone in the acute phase of Ph1 positive leukemia. Cancer 43: 426–434

    Article  PubMed  CAS  Google Scholar 

  18. Kantarjian HM, Keating MJ, Walters RS, McCredie KB, Smith TL, Talpaz M, Beran M, Cork A, Trujillo JM, Freireich EJ (1986) Clinical and prognostic features of Philadelphia chromosome- negative chronic myelogenous leukemia. Cancer 58: 2023–2030

    Article  PubMed  CAS  Google Scholar 

  19. Kerndrup G, Pedersen B, Ellegaard J, Hokland P (1986) Prognostic significance of some clinical, morphological and cytogenetic findings in refractory anaemia ( RA) and RA with sideroblasts. Blut 52: 35–43

    Google Scholar 

  20. Knapp RH, Dewald GW, Pierre RV (1985) Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clin Proc 60: 507–516

    PubMed  CAS  Google Scholar 

  21. Miller JB, Testa JR, Lindgren V, Rowley JD (1985) The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis. Cancer 55: 582–591

    Article  PubMed  CAS  Google Scholar 

  22. Mitelman F (1985) Catalog of chromosome aberrations in cancer, 2nd edn. Liss, New York

    Google Scholar 

  23. Mitelman F (1986) Geographic heterogeneity of chromosome aberrations in hematologic disorders. Cancer Genet Cytogenet 20: 203–208

    Article  PubMed  CAS  Google Scholar 

  24. Mödder B, Zankovich R, Thiele J, Kremer B, Fonatsch C, Fischer R, Diehl V (1987) Die primäre (essentielle) Thrombozythämie - klinische Befunde, Verlauf und Therapie bei 26 Patienten. Med Klin 82: 635–646

    Google Scholar 

  25. Morrison-DeLap SJ, Kuffel DG, Dewald GW, Letendre L (1986) Unbalanced 1;7 translocation and therapy-induced hematologic disorders: a possible relationship. Am J Hematol 21: 39–47

    Article  PubMed  CAS  Google Scholar 

  26. Nowell PC, Hungerford DA (1960) A minute chromosome in human chronic granulocytic leukemia. Science 132: 1497

    Google Scholar 

  27. Nowell PC, Besa EC, Stelmach T, Finan JB (1986) Chromosome studies in preleukemic states. V. Prognostic significance of single versus multiple abnormalities. Cancer 58: 2571–2575

    Google Scholar 

  28. O’Malley FM, Garson OM (1985) Chronic granulocytic leukemia: correlation of blastic transformation type with karyotypic evolution. Am J Hematol 20: 313–323

    Article  PubMed  Google Scholar 

  29. Potter AM, Watmore AE, Cooke P, Lilleyman JS, Sokol RJ (1981) Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukaemia. Br J Cancer 44: 51–54

    Article  PubMed  CAS  Google Scholar 

  30. Prakash O, Yunis JJ (1984) High resolution chromosomes of the t(9;22) positive leukemias. Cancer Genet Cytogenet 11: 361–367

    Article  PubMed  CAS  Google Scholar 

  31. Pugh WC, Pearson M, Vardiman JW, Rowley JD (1985) Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment. Br J Haematol 60: 457–467

    Article  PubMed  CAS  Google Scholar 

  32. Rosenthal S, Canellos GP, Whang-Peng J, Gralnick HR (1977) Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. Am J Med 63: 542–547

    Google Scholar 

  33. Rowley JD (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290–291

    Article  PubMed  CAS  Google Scholar 

  34. Rowley JD (1978) Chromosome abnormalities in the acute phase of CML. Virchows Arch [B] 29: 57–63

    CAS  Google Scholar 

  35. Rowley JD (1983) Human oncogene locations and chromosome aberrations. Nature 301: 290–291

    Article  PubMed  CAS  Google Scholar 

  36. Sandberg AA, Kaiser-McCaw Hecht B, Hecht F (1985) Nomenclature: the Philadelphia chromosome or Ph without superscript. Cancer Genet Gytogenet 14: 1

    Article  CAS  Google Scholar 

  37. Sandberg AA, Gemmill RM, Hecht BK, Hecht F (1986) The Philadelphia chromosome: a model of cancer and molecular genetics. Cancer Genet Cytogenet 21: 129–146

    Article  PubMed  CAS  Google Scholar 

  38. Scheres JMJC, Hustinx TWJ, Geraedts JPM, Leeksma CHW, Meitzer PS (1985) Translocation 1;7 in hematologic disorders: a brief review of 22 cases. Cancer Genet Cytogenet 18: 207–213

    Article  PubMed  CAS  Google Scholar 

  39. Spring B, Fonatsch C, Müller C, Pawelec G, Kömpf J, Wernet P, Ziegler A (1985) Refinement of HLA gene mapping with induced B-cell line mutants. Immunogenetics 21: 277–291

    Article  PubMed  CAS  Google Scholar 

  40. Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Gutterman JU (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. N Engl J Med 314: 1065–1069

    Article  PubMed  CAS  Google Scholar 

  41. Testa JR, Kanofsky JR, Rowley JD, Baron JM, Vardiman JW (1981) Karyotypic patterns and their clinical significance in polycythemia vera. Am J Hematol 11: 29–45

    Article  PubMed  CAS  Google Scholar 

  42. Third International Workshop on Chromosomes in Leukemia (1981) Report on essential thrombocythemia. Cancer Genet Cytogenet 4: 138–142

    Article  Google Scholar 

  43. Tricot G, Boogaerts MA, de Wolf-Peeters C, van den Berghe H (1985) The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations. Br J Haematol 59: 659–670

    CAS  Google Scholar 

  44. Van den Berghe H, Broeckaertvan Orshoven A, Louwagie A, Verwilghen R, Michaux JL, Sokal G (1979) Transformation of polycythemia vera to myelofibrosis and late appearance of a 5q- chromosome anomaly. Cancer Genet Cytogenet 1: 157–167

    Article  Google Scholar 

  45. Whang-Peng J, Canellos GP, Carbone PP, Tjio JH (1968) Clinical implications of cytogenetic variants in chronic myelocytic leukemia ( CML ). Blood 32: 755–766

    Google Scholar 

  46. Yunis JJ, Rydell RE, Oken MM, Arnesen MA, Maer MG, Lobell M (1986) Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 67: 1721–1730

    PubMed  CAS  Google Scholar 

  47. Ziegler A, Zimmer FJ, Fonatsch C, So A, Trowsdale J (1985) Mapping of HLA class I and class II genes using HLA deletion mutant cell lines. Eighth International Workshop on Human Gene Mapping. Cytogenet Cell Genet 40: 788s

    Google Scholar 

Download references

Authors
  1. C. Fonatsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Gradl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Innere Medizin und Poliklinik, Universitätsklinikum Rudolf Virchow, Spandauer Damm 130, 1000, Standort Charlottenburg, Berlin 19, Germany

    Dieter Huhn

  2. II. Innere Abteilung, Krankenhaus Moabit, Turmstraße 21, 1000, Berlin 21, Germany

    Klaus Peter Hellriegel

  3. Innere Klinik und Poliklinik(Tumorforschung), Universitätsklinikum Essen, Hufelandstraße 55, 4300, Essen 1, Germany

    Norbert Niederle

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fonatsch, C., Gradl, G. (1988). Cytogenetic Findings in Myeloproliferative Disorders. In: Huhn, D., Hellriegel, K.P., Niederle, N. (eds) Chronic Myelocytic Leukemia and Interferon. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73526-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73526-4_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-19067-7

  • Online ISBN: 978-3-642-73526-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation